Figure 1From: Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension Mean MINICHAL scores per patient at different times from the start of antihypertensive treatment. Not all patients completed all HRQoL instruments at each time point.Back to article page